Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | genetic association 0.40 (overall 0.24) | 0.40 |
| cell type Human Protein Atlas | cell type enhanced outside the brain (retinal pigment epithelial cells) | 0.10 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | no papers tie it to Parkinson's yet | 1.00 |
| pathways Reactome | 3 pathways; mostly other | 0.30 |
No case: the score is under the bar. Receipt 1741
Sealed predictions
- F2RL2 in dopamine neurons, braak+0.37 (p 0.321) → +0.19 (p 0.631)receipt 1748
Swarm cases
receipt 1748: F2RL2 in dopamine neurons, braak
- power
- full sample +0.24 (p 0.346, n 18), 95% CI -0.26 to +0.63. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.22 (p 0.379, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.12 (p 0.640, n 18). could be the mix.
- skeptic
- leave-one-out range +0.12 to +0.38, sign flips 0; without severely affected donors +0.24 (p 0.346, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for F2RL2 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts